Eosinophilic pneumonia in allergological practice
- 作者: Tsarev S.1
-
隶属关系:
- National Research Center – Institute of Immunology Federal Medical-Biological Agency of Russia
- 期: 卷 18, 编号 1 (2021)
- 页面: 32-40
- 栏目: Reviews
- URL: https://journals.rcsi.science/raj/article/view/121599
- DOI: https://doi.org/10.36691/RJA1413
- ID: 121599
如何引用文章
全文:
详细
In this article, current data on pulmonary eosinophilia are presented. Pulmonary eosinophilia is defined as the infiltration of eosinophils into the airways, interstitia, and alveoli. There are diverse processes in etiology, the common feature of which is the presence of pulmonary eosinophilic infiltrates, and as a rule, peripheral blood eosinophilia. Causes of pulmonary eosinophilia include various infections, medications, parasites, autoimmune processes, malignancies, and presence of obstructive pulmonary diseases. A unified classification of pulmonary eosinophilia is lacking, and instead, various versions of classifications have been presented. The most convenient classification option for use is also distinguished. This article discusses the historical transformation of the term “eosinophilic pneumonia” in the field of allergology, showing the lack of unambiguity in the concept of “eosinophilic pneumonia”, as well as the location of eosinophilic pneumonia in the pulmonary eosinophilia section. Eosinophilic pneumonia is defined as a disease characterized by an increase in the eosinophil content in the pulmonary tissue or bronchoalveolar lavage fluid. Most eosinophilic pneumonias are associated with peripheral blood eosinophilia. Two main variants of the disease are acute and chronic eosinophilic pneumonias. Thus, various ways to formulate diagnoses in various cases of eosinophilic pneumonia have been proposed.
作者简介
Sergey Tsarev
National Research Center – Institute of Immunology Federal Medical-Biological Agency of Russia
编辑信件的主要联系方式.
Email: sv.tsarev@nrcii.ru
ORCID iD: 0000-0003-2235-243X
SPIN 代码: 4590-9457
Scopus 作者 ID: 42462654000
MD, Dr. Sci. (Med.), Assistant professor
俄罗斯联邦, 24, Kashirskoye shosse, Moscow, 115522参考
- Pytskiy VI, Adrianova NV, Artomasova AV. Allergic diseases. Series: Library of the practical doctor. The most important issues of internal medicine. Moscow: Meditsina; 1991. 368 p. (In Russ).
- Samsonova MV, Chernyaev AL. Eosinophilia of the lungs. Prakticheskaya pulmonologiya. 2016;(1):56–60. (In Russ).
- Rose DM, Hrncir DE. Primary eosinophilic lung diseases. Allergy Asthma Proc. 2013;34(1):19–25. doi: 10.2500/aap.2013.34.3628
- Crowe M, Robinson D, Sagar M, et al. Chronic eosinophilic pneumonia: clinical perspectives. Ther Clin Risk Manag. 2019;15:397–403. doi: 10.2147/TCRM.S157882
- Jeong YJ, Kim KI, Seo IJ, et al. Eosinophilic lung diseases: a clinical, radiologic, and pathologic overview. Radiographics. 2007;27(3):617–637. doi: 10.1148/rg.273065051
- Lоffler W. Zur differentialdiagnose der lungeninfiltrierungen II. Ueber fluchtige succedanininfiltrate (mit Eosinophilie). Beitr Klin Tuberk. 1932;79:368–382. doi: 10.1007/bf02079221
- Weingarten RJ. Tropical eosinophilia. Lancet. 1943;241:103–105. doi: 10.1016/s0140-6736(00)70615-5
- Cottin V. Diseases Elung. Eosinophilic lung diseases. Clin Chest Med. 2016;37(3):535–556. doi: 10.1016/j.ccm.2016.04.015
- Carrington CB, Addington WW, Goff AM, et al. Chronic eosinophilic pneumonia. N Engl J Med. 1969;280(15):787–798. doi: 10.1056/nejm196904102801501
- Leon-Kindberg M, Adida P, Rosenthal L. Pneumopathie et eosinophiles. Presse Med (Paris) 1940;48:277–278.
- To M, Kono Y, Yamawaki S, et al. A case of chronic eosinophilic pneumonia successfully treated with mepolizumab. J Allergy Clin Immunol Pract. 2018;6(5):1746–1748.e1. doi: 10.1016/j.jaip.2018.06.017
- Kaya H, Gümüş S, Uçar E. Omalizumab as a steroid-sparing agent in chronic eosinophilic pneumonia. Chest. 2012;142(2):513–516. doi: 10.1378/chest.11-1881
- Allen JN, Pacht ER, Gadek JE, Davis WB. Acute eosinophilic pneumonia as a reversible cause of noninfectious respiratory failure. N Engl J Med. 1989;321(9):569–574. doi: 10.1056/nejm198908313210903
- Badesch DB, King TE Jr, Schwarz MI. Acute eosinophilic pneumonia: a hypersensitivity phenomenon? Am Rev Respir Dis. 1989;139(1):249–252. doi: 10.1164/ajrccm/139.1.249
- Uchiyama H, Suda T, Nakamura Y, et al. Alterations in smoking habits are associated with acute eosinophilic pneumonia. Chest. 2008;133(5):1174–1180. doi: 10.1378/chest.07-2669
- De Giacomi F, Vassallo R, Yi ES, Ryu JH. Acute Eosinophilic Pneumonia. Causes, Diagnosis, and Management. Am J Respir Crit Care Med. 2018;197(6):728–736. doi: 10.1164/rccm.201710-1967CI
- Solomon J, Schwarz M. Drug-, toxin-, and radiation therapy-induced eosinophilic pneumonia. Semin Respir Crit Care Med. 2006;27:192–197. doi: 10.1055/s-2006-939522
- Bartal C, Sagy I, Barski L. Drug-induced eosinophilic pneumonia. Medicine. 2018;97(4):e9688. doi: 10.1097/MD.0000000000009688
- Jin F, Wang ST. Chronic eosinophilic pneumonia after trastuzumab and radiation therapy for breast cancer. Medicine. 2019;98(1):e14017. doi: 10.1097/MD.000000000001401
- Alonso RA, Zea-Mendoza AC, Salazar-Vallinas JM, et al. Toxic oil syndrome: a syndrome with features overlapping those of various forms of scleroderma. Semin Arthr Rheum. 1986;15(3):200–212. doi: 10.1016/0049-0172(86)90017-x
- Allen JA, Peterson A, Sufit R, et al. Post-epidemic eosinophilia-myalgia syndrome associated with L-tryptophan. Arthr Rheum. 2011;63(11):3633–3639. doi: 10.1002/art.30514
- Dallos T, Heiland G, Strehl J, et al. CCL17/thymus and activation-related chemokine in Churg-Strauss syndrome. Arthritis Rheum. 2010;62(11):3496–3503. doi: 10.1002/art.27678
- Wechsler ME, Akuthota P, Jayne D, et al. Mepolizumab or placebo for eosino philic granulomatosis with polyangiitis. N Engl J Med. 2017;376(20):1921–1932. doi: 10.1056/NEJMoa1702079
- Wechsler ME. Pulmonary eosinophilic syndromes. Immunol. Allergy Clin. North Am. 2007;27(3):477–492. doi: 10.1016/j.iac.2007.07.005
补充文件
![](/img/style/loading.gif)